HKIG Immune Technology
We are a team that has more than 20 years of experience in the development of immunodiagnostic reagents such as monoclonal antibodies. The antibody discovery platform (EFFIMABTM) established in HKIG is an innovated cutting-edge technology that has been recognized by world-renowned immunodiagnostic manufacturers to whom HKIG established strategic partnership for the development of antibody reagents.
Professional immunodiagnostic reagent raw materials and Solution Provider
We have established a high-standard production center (Huzhou) with advanced facilities and engineers that possess rich experience in the production of immunodiagnostic reagents and a R&D center (Hangzhou) led by senior immunology scientists.
HKIG is a talent training base or strategic partner to many high-level scientific research institutions or universities with whom jointly promote the R&D and industrialization of innovative products and technologies that represent the development direction of the industry.
The purpose of HKIG is to become a reliable partner to immunodiagnostic enterprises with high-quality products and high-level services. HKIG endeavors to create the greatest value for customers, and to help customers obtain important upstream advantages in the rapidly growing IVD market.